WebDisclosure WebDisclosure
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases HausVorteil AG Remove
  1. Home
  2. Companies
  3. HausVorteil AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 11:05, 3 days 19 hours ago

    HausVorteil AG's Profitable Equity Release Strategy

    Real Estate Profitability Investment HausVorteil AG Equity Release
  • BRIEF

    published on 12/01/2025 at 11:05, 3 days 19 hours ago

    La stratégie de libération rentable des capitaux propres de HausVorteil AG

    Investissement Rentabilité Immobilier HausVorteil AG Libération De Fonds Propres
  • PRESS RELEASE

    published on 12/01/2025 at 11:00, 3 days 19 hours ago

    Original-Research: HausVorteil AG (von Parmantier & Cie. GmbH): Buy

    HausVorteil AG's scalable equity release business model already profitable with high demand and access to financing determining growth. For more details, download the research from PCR_HausVorteil_2025_12_01_EN
    Scalable Growth Profitable Business Model HausVorteil AG Equity Release Access To Financing
    Logo of HausVorteil AG
Accesswire
  • Published on 12/05/2025 at 02:35, 4 hours 1 minute ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 4 hours 6 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 5 hours 36 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 7 hours 31 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 7 hours 36 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 3 hours 6 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 6 hours 45 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 10 hours 11 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 10 hours 21 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 11 hours 25 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:14, 12 hours 21 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 12 hours 36 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

  • Published on 12/04/2025 at 18:00, 12 hours 36 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 12 hours 51 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions

  • Published on 12/04/2025 at 17:45, 12 hours 51 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy